9 results
8-K
EX-99.1
GUTS
Fractyl Health, Inc. Common Stock
30 Jul 24
Regulation FD Disclosure
7:01am
for the majority of patients who want a sustainable solution for their obesity.”
In prior clinical studies of Revita conducted in people with T2D in the U.S
10-Q
2024 Q1
GUTS
Fractyl Health, Inc. Common Stock
13 May 24
Quarterly report
4:06pm
of medical devices among EU member States.
The MDR, among other things, is intended to establish a uniform, transparent, predictable and sustainable … in achieving sustainable, reproducible, and scalable production. Any of these factors may prevent us from completing our preclinical or clinical
10-K
2023 FY
GUTS
Fractyl Health, Inc. Common Stock
1 Apr 24
Annual report
7:15am
is an effective drug at lowering blood glucose in controlled clinical trials but presents significant limitations as a sustainable therapy … , predictable and sustainable regulatory framework across the EU for medical devices and ensures a high level of safety and health while supporting
424B4
GUTS
Fractyl Health, Inc. Common Stock
2 Feb 24
Prospectus supplement with pricing info
4:18pm
.
The MDR, among other things, is intended to establish a uniform, transparent, predictable and sustainable regulatory framework across the EU and EEA … , or that such development problems can be solved. We may also experience delays and challenges in achieving sustainable, reproducible, and scalable
S-1/A
81iagw0dntbog3qpfzs1
29 Jan 24
IPO registration (amended)
6:09am
S-1
2asq5t8kvjykaqh4a2s2
14 Dec 23
IPO registration
3:39pm
DRS/A
w85wkdwmreuxhy
21 Sep 23
Draft registration statement (amended)
12:00am
DRS/A
o1e5l
22 Aug 23
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next